Filing Flows › ICU Medical (ICUI) › Q1 2025
ICU Medical (ICUI) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 8, 2025
ICU Medical (ICUI) reported revenue of $605M for the first quarter 2025 (Q1 2025), +7% from a year earlier and -4% from the quarter before. Operating margin was 2.1%, net loss $15.5M (2.6% of revenue).
ICU Medical, Q1 2025: revenue $605M (+7% year over year), operating margin 2.1%, net loss $15.5M, operating cash flow $51.3M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $605M | -4% | +7% |
| Operating profit | $12.9M | — | — |
| Net earnings | −$15.5M | — | — |
| Operating cash flow | $51.3M | +28% | +12% |
| Free cash flow | $36.7M | — | +21% |
What changed
Revenue was $604.7M in Q1 2025, up 7% year over year and down 4% from the previous quarter. Infusion Consumables was the largest line at 44% of revenue. Infusion Consumables added $22.2M year over year (up 9%), 58% of the total change.
Gross margin was 34.7%, up 2.1 points from a year earlier. Operating profit was $12.9M, a 2.1% margin (up 4.0 points year over year). Operating expenses grew 1% against revenue growth of 7%. The quarter ended with a net loss of $15.5M, narrower than the previous quarter's $23.8M loss. Net interest and other expense of $23.8M was the main reason.
Operating cash flow was $51.3M (up 12% year over year). Non-cash charges added back $49.4M of depreciation and amortization and $12.2M of share-based compensation. Working capital and other items added $5.2M. After purchase of property, plant and equipment, net ($14.6M), free cash flow as the company reports it was $36.7M.
Questions
What was ICU Medical's revenue in the first quarter 2025?
ICU Medical (ICUI) reported revenue of $605M for the first quarter 2025 (Q1 2025), +7% from a year earlier and -4% from the quarter before.
Was ICU Medical profitable in the first quarter 2025?
Operating profit was $12.9M (2.1% of revenue) and net loss $15.5M.
Source: ICU Medical 10-Q on SEC EDGAR.